Nautilus Biotechnology Overview
Latest PEG ratio for Nautilus Biotechnology: 56.54 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow56.54
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
As of the most recent data, NAUT shows a PEG ratio of 56.54. That is above the Healthcare sector average of 2.89. Scroll down for historical charts and peer comparison views.
The Healthcare sector average PEG ratio is about 2.89. Nautilus Biotechnology is at 56.54, which is higher that average. That is roughly 1855.7% above the sector mean. Use the comparison chart on this page to see how NAUT stacks up against individual peers as well.
Investors watch NAUT's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Nautilus Biotechnology's latest reading is 56.54. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this peg ratio page, Stockcircle has Nautilus Biotechnology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 56.54) with ownership activity and broader fundamentals.
The Healthcare average PEG ratio is about 2.89, while NAUT is at 56.54. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
